Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | CHKA | P35790 | 2/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31272185 | 1.00 | LMNA (0.65) | LMNANPSR1L3MBTL1KDM4ECYP1A2 | |
| SCHEMBL8085263 | 0.98 | LMNA (0.61) | LMNANPSR1L3MBTL1KDM4ECYP1A2 | |
| Fluoride Ion SCHEMBL2453932 | 0.96 | LMNA (0.59) | LMNANPSR1L3MBTL1KDM4ECYP1A2 | |
| Bromide SCHEMBL6981181 | 0.96 | LMNA (0.59) | LMNANPSR1L3MBTL1KDM4ECYP1A2 | |
| Bromide SCHEMBL31255661 | 0.96 | LMNA (0.59) | LMNANPSR1L3MBTL1KDM4ECYP1A2 | |
| Hydrochloric Acid SCHEMBL23611562 | 0.80 | CALM1 (0.44) | LMNAL3MBTL1KDM4EHTT | |
| SCHEMBL2737208 | 0.78 | LMNA (0.92) | LMNANPSR1L3MBTL1KDM4ECYP1A2 | |
| SCHEMBL28842894 | 0.78 | CALM1 (0.45) | LMNAL3MBTL1KDM4EHTT | |
| Hydrochloric Acid SCHEMBL11558609 | 0.77 | LMNA (0.65) | LMNANPSR1L3MBTL1KDM4ECYP1A2 | |
| Hydrochloric Acid SCHEMBL5155050 | 0.77 | LMNA (0.65) | LMNANPSR1L3MBTL1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0615855-B1 | Recording sheets containing pyridinium and/or piperazinum compounds | XEROX CORP (US) | 1997-05-14 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| US-5441795-A | Piperazinium compounds | XEROX CORPORATION (US) | 1995-08-15 | — | — | US | claimed |
| EP-0615855-A1 | Recording sheets containing pyridinium and/or piperazinum compounds | XEROX CORPORATION (US) | 1994-09-21 | — | — | EP | claimed |
| EP-0397474-A2 | Photosensitive composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1990-11-14 | — | — | EP | claimed |
| US-20250386726-A1 | AMBIPOLAR MOLECULE, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF | CONTEMPORARY AMPEREX FUTURE ENERGY RESEARCH INSTITUTE (SHANGHAI) LIMITED (CN) | 2025-12-18 | — | — | US | disclosed |
| US-20250374822-A1 | AMBIPOLAR MOLECULE, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF | CONTEMPORARY AMPEREX FUTURE ENERGY RESEARCH INSTITUTE (SHANGHAI)LIMITED (CN) | 2025-12-04 | — | — | US | disclosed |
| EP-4656623-A1 | AMPHIPATHIC MOLECULE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Contemporary Amperex Future Energy Research Institute (Shanghai) Limited (CN) | 2025-12-03 | — | — | EP | disclosed |
| EP-4635948-A1 | AMPHIPHILIC MOLECULE, PREPARATION METHOD THEREFOR AND USE THEREOF | Contemporary Amperex Future Energy Research Institute (Shanghai) Limited (CN) | 2025-10-22 | — | — | EP | disclosed |
| WO-2024260068-A1 | PEROVSKITE MATERIAL AND PREPARATION METHOD THEREFOR, PHOTOELECTRIC DEVICE AND ELECTRIC DEVICE | 宁德时代未来能源(上海)研究院有限公司 | 2024-12-26 | — | — | WO | disclosed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | disclosed |
| US-5441795-A | Piperazinium compounds | XEROX CORPORATION (US) | 1995-08-15 | — | — | US | disclosed |
| EP-0615855-A1 | Recording sheets containing pyridinium and/or piperazinum compounds | XEROX CORPORATION (US) | 1994-09-21 | — | — | EP | disclosed |
| US-5100768-A | Photoresists for integrated circuits, polyvinyl phenol and nitrogen containing heterocycle | KABUSHIKI KAISHA TOSHIBA (JP) | 1992-03-31 | — | — | US | disclosed |
| EP-0397474-A2 | Photosensitive composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1990-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250386726-A1 | AMBIPOLAR MOLECULE, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF | BLM, SSB, BRI3BP | ACHE 3104/4885LMNA 1154/4885NPSR1 3245/4885 |
| US-20250374822-A1 | AMBIPOLAR MOLECULE, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF | SSB, BRI3BP, BMI1 | ACHE 2800/4885LMNA 1023/4885NPSR1 3220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.